Recent studies have revealed that LARP1 drives oncogenesis, and higher levels of LARP1 protein correspond with a poor prognosis in NSCLC, colorectal cancer, prostate cancer, ovarian cancer, HCC, and ICC (45–51). Here, LARP1 is linked to Familial prostate cancer.